YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that ...
TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and ...
Zura Bio Ltd, which went public on March 21, 2023, is a clinical-stage biotechnology company dedicated to developing treatments for immune and inflammatory disorders. With a market capitalization of ...
Entera Bio Ltd. ENTX rose 15.71% in after-hours trading on Wednesday, climbing to $1.62 following the disclosure of a Securities and Exchange Commission filing by Director Steven D. Rubin. The stock ...
Entera Bio Ltd. reported its financial results for Q1 2025, highlighting significant advancements in its development of oral peptide therapies, particularly EB613, an oral anabolic treatment for ...
NEW YORK--(BUSINESS WIRE)--Peak Bio Co., Ltd. (“Peak Bio”), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory ...
Wearable Devices expands its AI-powered LMM technology into predictive health monitoring and cognitive state analytics, enhancing real-time health insights. Wearable Devices Ltd., a technology company ...
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions Ltd (“Bio-Thera”) announced today that it has reached a licensing agreement with Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter ...
GUANGZHOU, China, Jan. 14, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd. today announced the publication of the Phase I clinical study results for BAT4406F, an ADCC-enhanced fully humanized anti-CD20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results